AMARIN CORP PLC\UK Other Non-Current Assets
AMARIN CORP PLC\UK (AMRN) had Other Non-Current Assets of $3.95 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-07-29
- 2026-06-30: Other Assets, Noncurrent $3.95M.
- 2026-03-31: Other Assets, Noncurrent $1.01M.
- 2025-12-31: Other Assets, Noncurrent $1.07M; Other Assets, Noncurrent as first filed $1.05M.
- 2025-09-30: Other Assets, Noncurrent $1.11M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $3.95M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $1.01M 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $1.07M 10-Q · filed 2026-07-29 | $1.05M 10-K · filed 2026-03-02 |
| 2025-09-30 | $1.11M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $1.14M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $1.17M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $1.21M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $1.25M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $1.29M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $1.32M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $1.36M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $1.40M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $1.60M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $1.64M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $458.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $456.00K 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $456.00K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $456.00K 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $456.00K 10-K · filed 2023-03-01 | |
| 2021-09-30 | $456.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $456.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $456.00K 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $432.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $1.07M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.07M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $1.07M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $1.07M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.07M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.10M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $643.00K 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $174.00K 10-K · filed 2020-02-25 | |
| 2018-09-30 | $174.00K 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $174.00K 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $174.00K 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $174.00K 10-K · filed 2019-02-27 | |
| 2017-09-30 | $174.00K 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $173.00K 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $652.00K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $741.00K 10-K · filed 2018-02-27 | |
| 2016-09-30 | $682.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $174.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $174.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $174.00K 10-K · filed 2017-03-01 | $2.04M 10-K · filed 2016-02-25 |
| 2015-09-30 | $2.30M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $2.51M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $2.70M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $2.83M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $4.82M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $5.06M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $3.02M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $4.36M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $5.33M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $5.33M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $5.33M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $4.95M 10-K · filed 2014-02-27 | |
| 2012-09-30 | $15.67M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $2.48M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $1.66M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $2.24M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $3.53M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $2.87M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $2.17M 10-Q · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |